A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies-Reference-Cited by-同舟云学术

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies

Published:2022-01 Issue: Volume:66 Page:46-52
ISSN:1871-6784
Container-title:New Biotechnology
language:en
Short-container-title:New Biotechnology

Author:

Mravinacova Sara,Jönsson Malin,Christ Wanda,Klingström Jonas,Yousef Jamil,Hellström Cecilia,Hedhammar My,Havervall Sebastian,Thålin Charlotte,Pin Elisa,Tegel Hanna,Nilsson Peter,Månberg Anna,Hober Sophia

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Bioengineering,Biotechnology

Reference23 articles.

1. Coronavirus resource center;Hopkins,2021

2. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings;Yang;Lancet Infect Dis,2004

3. Reliability of RT-PCR tests to detect SARS-CoV-2: risk analysis;Bezier;Int J Metrol Qual Eng,2020

4. A serological assay to detect SARS-CoV-2 seroconversion in humans;Amanat;Nat Med,2020

5. Antibody responses to SARS-CoV-2 in patients with COVID-19;Long;Nat Med,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement;Viruses;2023-07-05

2. A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity;Frontiers in Immunology;2022-11-30

3. Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals;Med;2022-02

4. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples;Integrated Methods in Protein Biochemistry: Part A;2022